Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Los Angeles, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Armata Pharmaceuticals, Inc. has filed 1,149 SEC EDGAR filings since 06 Feb 1996

SEC filing history

Showing 451-475 of 696 matching filings.

Per page
25
Current page
19
4

FORM 4

Filing date
29 Dec 2016
Reporting date
27 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37544

FORM 8-K

Filing date
19 Dec 2016
Reporting date
19 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Dec 2016
Reporting date
09 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Dec 2016
Reporting date
09 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37544

8-K

Filing date
05 Dec 2016
Reporting date
05 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-44887

SC 13G

Filing date
25 Nov 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37544

8-K

Filing date
17 Nov 2016
Reporting date
17 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-213421

424B4

Filing date
17 Nov 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS EX File 333-213421

POS EX

Filing date
17 Nov 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-213421

EFFECT filing

Filing date
16 Nov 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
16 Nov 2016
Reporting date
12 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-44887

RANDAL J KIRK SC 13D A NO 2 11-12-2016 (AMPLIPHI BIOSCIENCES CORP)

Filing date
16 Nov 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-213421

S-1/A

Filing date
16 Nov 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-213421

S-1/A

Filing date
14 Nov 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37544

8-K

Filing date
14 Nov 2016
Reporting date
12 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
10 Nov 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
10 Nov 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-213421

S-1/A

Filing date
10 Nov 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37544

FORM 8-K

Filing date
25 Oct 2016
Reporting date
25 Oct 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-213421

S-1/A

Filing date
03 Oct 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37544

FORM 8-K

Filing date
29 Sep 2016
Reporting date
27 Sep 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
FWP File 333-213421

FWP

Filing date
20 Sep 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-213421

S-1/A

Filing date
14 Sep 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
09 Sep 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .